Invizius.com


Keyword Suggestion

Invizius
Invizius limited
Invizius biocity



Domain Informations

Invizius.com lookup results from whois.godaddy.com server:
  • Domain created: 2017-02-23T15:27:43Z
  • Domain updated: 2022-10-10T08:29:47Z
  • Domain expires: 2025-02-23T15:27:43Z 0 Years, 304 Days left
  • Website age: 7 Years, 60 Days
  • Registrar Domain ID: 2099917088_DOMAIN_COM-VRSN
  • Registrar Url: http://www.godaddy.com
  • Registrar WHOIS Server: whois.godaddy.com
  • Registrar Abuse Contact Email: [email protected]
  • Registrar Abuse Contact Phone: 480-624-2505
  • Name server:
    • NS15.DOMAINCONTROL.COM
    • NS16.DOMAINCONTROL.COM

Domain Provider Number Of Domains
godaddy.com 286730
namecheap.com 101387
networksolutions.com 69118
tucows.com 52617
publicdomainregistry.com 39120
whois.godaddy.com 32793
enomdomains.com 23825
namesilo.com 21429
domains.google.com 21384
cloudflare.com 20573
gmo.jp 18110
name.com 17601
fastdomain.com 14708
register.com 13495
net.cn 12481
ionos.com 12416
ovh.com 12416
gandi.net 12305
registrar.amazon.com 12111


Host Informations

  • IP address: 185.60.251.251
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Check all domain's dns records


See Web Sites Hosted on 185.60.251.251

Fetching Web Sites Hosted


Site Inspections


Port Scanner (IP: 185.60.251.251)

 › Ftp: 21
 › Ssh: 22
 › Telnet: 23
 › Smtp: 25
 › Dns: 53
 › Http: 80
 › Pop3: 110
 › Portmapper, rpcbind: 111
 › Microsoft RPC services: 135
 › Netbios: 139
 › Imap: 143
 › Ldap: 389
 › Https: 443
 › SMB directly over IP: 445
 › Msa-outlook: 587
 › IIS, NFS, or listener RFS remote_file_sharing: 1025
 › Lotus notes: 1352
 › Sql server: 1433
 › Point-to-point tunnelling protocol: 1723
 › My sql: 3306
 › Remote desktop: 3389
 › Session Initiation Protocol (SIP): 5060
 › Virtual Network Computer display: 5900
 › X Window server: 6001
 › Webcache: 8080


Spam Check (IP: 185.60.251.251)

 › Dnsbl-1.uceprotect.net:
 › Dnsbl-2.uceprotect.net:
 › Dnsbl-3.uceprotect.net:
 › Dnsbl.dronebl.org:
 › Dnsbl.sorbs.net:
 › Spam.dnsbl.sorbs.net:
 › Bl.spamcop.net:
 › Recent.dnsbl.sorbs.net:
 › All.spamrats.com:
 › B.barracudacentral.org:
 › Bl.blocklist.de:
 › Bl.emailbasura.org:
 › Bl.mailspike.org:
 › Bl.spamcop.net:
 › Cblplus.anti-spam.org.cn:
 › Dnsbl.anticaptcha.net:
 › Ip.v4bl.org:
 › Fnrbl.fast.net:
 › Dnsrbl.swinog.ch:
 › Mail-abuse.blacklist.jippg.org:
 › Singlebl.spamgrouper.com:
 › Spam.abuse.ch:
 › Spamsources.fabel.dk:
 › Virbl.dnsbl.bit.nl:
 › Cbl.abuseat.org:
 › Dnsbl.justspam.org:
 › Zen.spamhaus.org:


Email address with invizius.com

Found 1 emails of this domain
1. [email protected]

Recent Searched Sites

Oldskoolbutik.com (4 seconds ago) / US

Somarproductions.com (22 seconds ago) / US

Oxygengraphics.co.uk (7 seconds ago) / US

Varitrans.com.ar (2 seconds ago) / US

Dev-vpn.getadblock.com (40 seconds ago) / US

Almajed-company.com (2 seconds ago) / US

Journaldugeek.com (0 seconds ago) / US

Maths.qmul.ac.uk (15 seconds ago) / GB

Compasslegal.org (7 seconds ago) / US

Discountcontactlenses.com (1 seconds ago) / US

Shopdwfreshmarket.org (20 seconds ago) / US

Marcfisherfootwear.com (6 seconds ago) / CA

Kraftmacandcheese.com (51 seconds ago) / US

Directory.katiegoesplatinum.com (1 seconds ago) / US

Czyn.network (20 seconds ago) / US

Reportandrun.com (12 seconds ago) / US

Paraphrasing.io (36 seconds ago) / US

Mahalo.cz (41 seconds ago) / US

Stoadata.com (22 seconds ago) / US

Invizius.com (1 seconds ago) / DE

Websites Listing

We found Websites Listing below when search with invizius.com on Search Engine

About - Invizius dialyser edinburgh side effects of dialysis

About. Invizius is the trading name of Invizius Limited. Invizius Limited is a limited company registered in Scotland, UK, with registration number SC586903. Invizius Limited's registered office is at 5th Floor, 125 Princes Street, Edinburgh, EH2 4AD, UK. Invizius is registered for VAT in the UK, VAT number 290 2459 01.

Invizius.com

Technology - Invizius dialyser edinburgh side effects of ...

Invizius has identified and isolated this "invisibility cloak", and can manufacture it using standard, industry methods. By attaching the cloak to man-made medical device surfaces in contact with the blood, Invizius has created H-Guard ®, an advanced hemocompatible coating capable of preventing, at source, the blood's foreign body reactions.

Invizius.com

Invizius - Crunchbase Company Profile & Funding

Find More Contacts for Invizius. Andy Herbert. Co-Founder, CTO, Founder. Executive Management, Operations 2 emails found . View contacts for Invizius to access new leads and connect with decision-makers. View All Contacts . Details. Industries . Biotechnology. Health Care. Medical. Founded Date 2018; Founders Andy Herbert; Operating Status Active; Last …

Crunchbase.com

Invizius | FierceBiotech

2019-02-11  · Invizius aims to cloak the machine from the body by stealing a trick from the bacteria behind pneumonia and meningitis. By coating the device with a layer of proteins similar to the skin of the ...

Fiercebiotech.com

Solvay Ventures invests in Invizius – Plas.tv

“Invizius’s H-Guard™ product is a powerful anti-inflammatory used to coat the dialysis filter surface to ‘hide’ it and prevent an immune response with serious life-shortening cardiovascular complications,” explains CTO Dr Andy Herbert. This innovative technology also has potential for use with devices such as heart and lung machines, stents and grafts, or in organ and cell ...

Plas.tv

Invizius Announces Successful Series A Financing to ...

2021-05-06  · Invizius Limited is a late pre-clinical-stage biotechnology company developing treatments to suppress unwanted innate immune responses, focused initially on …

Wfmz.com

Invizius Closes £5.3M Series A Financing - FinSMEs

2021-05-07  · Invizius Limited, a Motherwell, Scotland, UK-based biotechnology company developing treatments to suppress unwanted innate immune responses, closed Series A financing of £5.3m.. The round was led ...

Finsmes.com

Invizius Announces Successful Series A to Develop Anti ...

2021-05-06  · Invizius Limited is a late pre-clinical-stage biotechnology company developing treatments to suppress unwanted innate immune responses, focused initially on reducing the life-threatening inflammatory effects of dialysis. Founded in 2017, the University of Edinburgh spin-out is developing its proprietary H-Guard® Priming Solution, comprising a novel protein that lines …

Downingventures.com

Invizius raises £2.75M for its protein coating that hides ...

2019-10-22  · FierceMedTech Fierce 15 winner Invizius has raised £2.75 million, or about $3.57 million, to help develop its system for mitigating the potential harms and risks of cardiovascular disease linked ...

Fiercebiotech.com

Invizius Announces Successful Series A Financing to ...

2021-05-06  · Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted innate immune responses, today announces that it has closed Series A financing of £5.3 million.

Finance.yahoo.com

Invizius Company Profile: Valuation & Investors | PitchBook

Invizius General Information Description. Operator of a biotech company intended to develop treatments to suppress unwanted innate immune responses. The company's product is an anti-inflammatory treatment for patients on hemodialysis and the solution comprises a novel protein that lines the inside of the dialysis filter and helps dialysis to take place undetected by the …

Pitchbook.com

Nicola Ann Broughton - Invizius - GetCompanyDetails.com

Nicola Ann Broughton is the director of 1 company. Nicola Ann Broughton was appointed director of INVIZIUS LIMITED on 27 September 2019, and its principal business activity is 21200 - Manufacture of ph 32500 - Manufacture of me. Get complete contact details like education details, employment histrory, phone/mobile number and email address below.

Getcompanydetails.com

Invizius Announces Successful Series A Financing to ...

2021-05-06  · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support

Bloomberg.com

Invizius raises £5.3 million to study treatment for ...

2021-05-11  · Invizius’ anti-inflammatory treatment for haemodialysis. Invizius has announced the closing of a Series A financing round worth £5.3 million. The Scottish biotechnology company will use this funding to complete a first-in-man safety study next year of its H-Guard Priming Solution, which is intended to reduce the life-threatening inflammatory effects of haemodialysis. …

Renalinterventions.net

Invizius Employee Details, Technology Stack and More ...

Find useful insights on Invizius’s employee, technology stack, location, news alerts and more at Slintel. Use Slintel to connect with top decision-makers at Invizius.

Slintel.com

5 Top Emerging Kidney Disease Startups Impacting The ...

Invizius – Dialysis. Dialysis treatment mimics the kidney’s functions of filtering and processing the impurities in the blood. The frequency of dialysis varies for each patient, depending on the severity of the kidney disorder. However, there is a risk of contracting cardiovascular complications due to an immune response against the foreign object. Startups are working on …

Startus-insights.com

INVIZIUS LIMITED - Free Company Check

2021-11-05  · Find out more information about INVIZIUS LIMITED. Our website makes it possible to view other available documents related to INVIZIUS LIMITED. You have at your disposal scanned copies of official documents submitted by the company at Companies House. These documents may contain Accounts, Annual Returns, Director appointments, Director …

Companieslist.co.uk

Eric Beard - Cellnovo | Invizius - GetCompanyDetails.com

Eric Beard was appointed director of INVIZIUS LIMITED on 07 November 2019, and its principal business activity is 21200 - Manufacture of ph 32500 - Manufacture of me. Get complete contact details like education details, employment histrory, …

Getcompanydetails.com


Domains Expiration Date Updated

Site Provider Expiration Date
vnypm.com godaddy.com 301 Days
formongde.com gabia.com 6 Years, 93 Days
environmentalstandards.info crazydomains.com -1 Years, -175 Days
miguelclaria.com donweb.com -2 Years, -9 Days
zvukiknig.net danesconames.com -1 Years, -258 Days
kdhaka.com hostinger.com -1 Years, -194 Days
loveproblemspecialistbabaji.in godaddy.com -1 Years, -363 Days
pivada.com nicproxy.com -2 Years, -55 Days
filesen.com namecheap.com -2 Years, -34 Days
sellisa.com name.com -1 Years, -237 Days

    Browser All

    .com4.3M domains   

    .org1M domains   

    .edu40.9K domains   

    .net607.7K domains   

    .gov15.9K domains   

    .us31.2K domains   

    .ca44.9K domains   

    .de556.7K domains   

    .uk465.9K domains   

    .it34.5K domains   

    .au46.4K domains   

    .co33.9K domains   

    .biz13.9K domains   

    .info36.7K domains   

    .fr37.2K domains   

    .eu24.6K domains   

    .ru193.7K domains   

    .ph5.6K domains   

    .in54.2K domains   

    .vn18.8K domains   

    .cn39.8K domains   

    .ro19.3K domains   

    .ch11.6K domains   

    .at10.2K domains   

    Browser All